Gastroenterology | Constipation
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
10 billion CFU serving; 1-3 serving/die
FUNCTIONALITY
Constipation
Scientific support
Human clinical trial
Yang, Y.X., M. He, G. Hu, J. Wei, P. Pages, X.H. Yang, and S. Bourdu-Naturel. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol 14.40 (2008): 6237-6243.
Gastroenterology | IBS -Irritable bowel syndrome
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
10 billion CFU serving; 1-3 serving/die
FUNCTIONALITY
Irritable bowel syndrome
Scientific support
Human clinical trial
Agrawal, A., Lesley A. Houghton, J. Morris, B. Reilly, D. Guyonnet, N. Goupil Feuillerat, A. Schlumberger, S. Jakob, and P. J. Whorwell. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Alimentary pharmacology & therapeutics 29.1 (2009): 104-114.
Guyonnet, D., O. Chassany, P. Ducrotte, C. Picard, M. Mouret, C‐H. Mercier, and C. Matuchansky. Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial. Alimentary pharmacology & therapeutics 26.3 (2007): 475-486.
